C12N 2330/30
Chemically synthesised
Official title: chemically synthesised
C12N2330/30 (Chemically synthesised) appears on 562 US grants and 1,182 published applications in this corpus.
Search patents in C12N- Granted patents
- 562
- Published applications
- 1,182
- Assignees
- 422
- Inventors
- 1,721
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 2 | 5 |
| 2003 | 3 | 23 |
| 2004 | 1 | 48 |
| 2005 | 2 | 102 |
| 2006 | 4 | 61 |
| 2007 | 3 | 52 |
| 2008 | 5 | 51 |
| 2009 | 16 | 67 |
| 2010 | 28 | 54 |
| 2011 | 33 | 54 |
| 2012 | 38 | 33 |
| 2013 | 30 | 42 |
| 2014 | 41 | 51 |
| 2015 | 36 | 55 |
| 2016 | 33 | 60 |
| 2017 | 34 | 53 |
| 2018 | 50 | 56 |
| 2019 | 36 | 47 |
| 2020 | 39 | 44 |
| 2021 | 32 | 43 |
| 2022 | 15 | 48 |
| 2023 | 28 | 37 |
| 2024 | 27 | 39 |
| 2025 | 12 | 33 |
| 2026 | 11 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of gene assembly using DNAzymes and use in DNA data storage5 May 2026US 12,618,061 B2Seagate Technology LLC
- Multimeric oligonucleotides with divided strands5 May 2026US 12,618,071 B2Mpeg La, LLC
- Targeted mutagenesis using base editors28 Apr 2026US 12,612,622 B2Qi Biodesign Biotechnology Company Limited
- Small RNA medicament for prevention and treatment of inflammation-related diseases and combination thereof28 Apr 2026US 12,612,631 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Methods and compositions for reprogramming cells14 Apr 2026US 12,600,968 B2The Regents of the University of Colorado, a body corporate
- Biological libraries and methods of preparing and using same8 Oct 2026US 2026/0308575 A1
- Capless and tailless therapeutic exogenous mrna and method to produce the same3 Sep 2026US 2026/0258405 A1University of South Alabama
- Translation enhancing nucleic acid compounds: aso coupled translation – upregulation 1 (act-up1) and uses thereof27 Aug 2026US 2026/0250676 A1Arnatar Therapeutics, Inc
- Modification of tRNA T-Stem for Enhancing N-Methyl Amino Acid Incorporation20 Aug 2026US 2026/0242776 A1The University of Tokyo
- In vitro enzymatical rna synthesis20 Aug 2026US 2026/0242838 A1DNA Script
Most cited
By later US patents
- RNA interference mediating small RNA molecules382US 7,056,704 B2MAX-PLANCK-GESELLSCHAFT zur FOERDERUNG der WISSENSCHAFTEN.e.V · 2006
- RNA interference mediating small RNA molecules333US 7,078,196 B2MAX-PLANCK-GESELLSCHAFT zur FOERDERUNG der WISSENSCHAFTEN.e.V · 2006
- In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom267US 5,624,803 AThe Regents of the University of California · 1997
- Modulation of apolipoprotein C-III expression262US 7,598,227 B2Isis Pharmaceuticals, Inc. · 2009
- In vivo production of small interfering RNAS that mediate gene silencing253US 7,691,995 B2University of Massachusetts · 2010